Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06728098

Safety and Tolerability Evaluation of Akkermansia Muciniphila

This is a randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of Akkermansia muciniphila Akk11 in healthy adult.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Fakultas Kedokteran Universitas Indonesia

Jakarta Pusat, Jakarta Special Capital Region, 10430, Indonesia

Location status: Recruiting

Location contact

Natalina Soesilawati

CONTACT

[email protected]

0217695513

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or Female subject age 18-60 years at screening.
  • Healthy subject according to investigator judgement based on screening data.
  • Subjects must be either of non-childbearing potential, or if of childbearing potential, they must be abstinent or have practiced adequate contraception for the entire study.
  • Subjects who have not smoked in the past 1 month prior to screening.
  • Subjects with a healthy and balanced diet, including adequate fiber intake in their food consumption.
  • Subject or subject's legally acceptable representatives have the ability to comply with the trial protocol.
  • Signed informed consent from the subject or subject's legally acceptable representatives (must be obtained before any trial related activities).

Exclusion criteria

  • History of or presence of diabetes, immunodeficiency disorders, or chronic illness.
  • Regular use of medications known to affect the gastrointestinal system or alter gut microbiota composition, including but not limited to antibiotics, and immunosuppressants.
  • Have continuous, daily use of probiotics or probiotic containing products within 1 month prior to randomization.
  • Pregnant, planning a pregnancy or lactating female (urinary pregnancy test will be applied to female subjects at screening).
  • Change type of diet during study.
  • Any known allergy or intolerance to any of the ingredients in the formulation of the product under study.
  • History of drug, alcohol or other substance abuse, or other factors that limit their ability to cooperate during the study.
  • History of or presence of eating disorder.
  • Subject whose condition does not make them eligible to the study, according to the investigator.

Treatment and study plan

Probiotic

Dietary Supplement

The experimental phase of this study had last 30 days and each patient will make 3 visits (d1,d15,d30).

Maltodextrin

Dietary Supplement

The experimental phase of this study had last 30 days and each patient will make 3 visits (d1,d15,d30).

Primary outcomes

  1. Changes in stool quality

    Time frame: 30 days

    Stool consistency (using the Bristol Stool Scale) from baseline to day 30. The Bristol Stool Scale is a tool to assess gut health by classifying feces into seven categories based on shape and consistency: types 1-2 indicate constipation, 3-4 are normal, and 5-7 suggest diarrhea.

Study contacts

Contact information is provided by the study sponsor or research team.

Natalina Soesilawati, Dr

CONTACT

[email protected]

0217695513

Vicky Achmad Ginanjar, bachelor

CONTACT

[email protected]

+62 21 7695513, 7515932 ext. +62

Sponsors and collaborators

Lead sponsor

Wecare Probiotics Co., Ltd.

Industry

Registry information

Official study title

Safety and Tolerability Evaluation of Heat-Inactivated Akkermansia Muciniphila Akk11: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Dec 11, 2024
Registry last updated
Jul 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.